Modern Diagnostic IPO Status Analyzed
The Modern Diagnostic & Research Centre IPO was incredibly popular! Investors showed a huge interest, with the entire offering – 4.1 million shares – being subscribed to 376.90 times over by the end of the subscription period. This means many people wanted to buy shares in the company, and the allotment process is now being finalized.
Key Points
- Huge investor demand: IPO oversubscribed 376.90 times.
- Shares offered: 4.1 million at ₹85-₹90 per share.
- Allotment finalized: Expected completion by January 5, 2026.
- Check status: BSE or MUFG Intime India websites.
- Debut on BSE SME: Planned for January 7, 2026.
- Funds usage: Equipment, working capital, and debt repayment.
About the IPO
The IPO raised ₹38.49 crore by selling new shares. Investors could buy 1,600 shares at a price between ₹85 and ₹90. The offering lasted from December 31, 2025, to January 2, 2026. Beeline Capital Advisors managed the sale of the shares.
What the Company Plans to Do with the Money
Modern Diagnostic intends to use the money raised to buy new medical equipment for its labs and clinics. They also plan to use some funds to cover day-to-day operating costs and pay off some existing debts. The rest will be used for general business expenses.
Grey Market Activity
Before the IPO launched, shares were trading privately on the grey market. These trades aren’t official and can be unreliable. The grey market price was around ₹106 per share, which is a 18% premium over the IPO price. Remember, grey market data isn’t a guarantee of how the stock will perform once it’s listed on the stock exchange.
Ultimately, a successful IPO signals investor confidence in the company’s future.
